Isolation and Characterization of Multiple Microbial Species From Diverse Healthy Adults
NCT05150184 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2023-09-07
Summary
Isolation and characterization of fecal/oral/skin/nasal/throat microbial species from a diverse cohort of healthy adults.
Conditions
- Human Microbiome
Interventions
- OTHER
-
Non-interventional
observational study, thus no different arm/groups
Sponsors & Collaborators
-
Reprocell Inc
collaborator UNKNOWN -
Serologix
collaborator UNKNOWN -
Danisco
lead INDUSTRY
Principal Investigators
-
Teresa A Lehman, PhD · Reprocell
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-17
- Primary Completion
- 2023-03-23
- Completion
- 2023-05-23
Countries
- United States
Study Locations
More Related Trials
-
Interaction Between Non-typhoid Salmonella, Host Microbiota, and Immune System During Acute Infection and Remission
NCT03494101 ·Status: UNKNOWN
-
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
NCT04668014 ·Status: COMPLETED
-
Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)
NCT03005379 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
NCT05622721 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)
NCT05153499 ·Status: TERMINATED ·Phase: PHASE3
-
The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection
NCT04675723 ·Status: COMPLETED
-
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
NCT04679324 ·Status: WITHDRAWN
-
A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years
NCT02561195 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.
NCT05107245 ·Status: COMPLETED
-
REBYOTA™ Prospective Registry
NCT05835219 ·Status: COMPLETED
-
Biogeography of the Oral Microbiome
NCT05672953 ·Status: COMPLETED
-
Controlled Human Infection Model Challenge/Rechallenge
NCT04992520 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)
NCT04891965 ·Status: COMPLETED ·Phase: PHASE1
-
The Clostridioides Difficile Trial of REC-3964
NCT06536465 ·Status: TERMINATED ·Phase: PHASE2
-
A Novel Fecal Sample Collection Method for Metagenomic Analyses
NCT05172414 ·Status: COMPLETED
-
PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"
NCT03187457 ·Status: COMPLETED ·Phase: NA
-
Oral Vaccination Against Clostridium Difficile Infection
NCT02991417 ·Status: TERMINATED ·Phase: PHASE1
-
Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation
NCT05739825 ·Status: RECRUITING
-
Evaluation of Gut Microbiota and Its Associated Resistome in FMT Donors and Recipients Due to Recurrent Clostridiodes Difficile Infection
NCT06533800 ·Status: NOT_YET_RECRUITING
-
Phase I Trial of a Single Dose of CRS3123
NCT01551004 ·Status: COMPLETED ·Phase: PHASE1
-
Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
NCT00485134 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
NCT03497806 ·Status: COMPLETED ·Phase: PHASE2
-
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment Program
NCT03350711 ·Status: SUSPENDED
-
Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
NCT05930197 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Rifaximin in Preventing Campylobacteriosis
NCT02280044 ·Status: COMPLETED ·Phase: PHASE2/PHASE3